CD BioSciences is a biotechnology company dedicated to promoting the high resolution 3Dmicroflu™ 3D bioprinting technology platform and high quality customised bioinks that can be applied to 3D printing organ and tissue micro-models. The construction of neurological disease models based on the 3Dmicroflu™ technology platform can be achieved in a precise and standardised process, allowing the printing of complex structures and the accurate reproduction of human neurological disease features in vitro. The 3D bioprinting experts from CD BioSciences are always looking forward to your inquiries and orders.
Neurological disorders occur in the central nervous system, peripheral nervous system and vegetative nervous system with the main symptoms being sensory, motor, consciousness and neurological dysfunction. Currently, the main categories of common neurological diseases are as follows.
(1) The first category is cerebrovascular disease. Cerebrovascular diseases include both ischaemic and haemorrhagic cerebrovascular diseases, which ultimately produce cerebrovascular lesions or blood flow disturbances that cause brain dysfunction. The main causative factors are neurological dysfunction caused by occlusion of blood vessel lumens, vessel rupture, vessel wall damage and abnormal blood components.
(2) The second category is senile degenerative diseases, which are degenerative diseases of the nervous system caused by neuronal degeneration and apoptosis. The clinical manifestations of neurodegenerative diseases fall into two main categories, including motor dysfunction and memory and cognitive dysfunction. Histopathological studies all show slow progressive apoptosis of neurons, mostly with abnormal aggregation of proteins within the nerve cells, forming inclusion bodies. Common neurodegenerative diseases include Parkinson's disease and Alzheimer's disease.
Research into the mechanisms of neurological disorders has received increasing attention in recent years, but the inherent complexity of the nervous system and the difficulty of dissecting brain tissue are major obstacles to current research.
In terms of current research into neurological diseases, researchers are still in the relatively early stages of understanding the mechanisms behind them, based on the complexity of the brain's structure and composition. How to advance research and development of drugs to treat neurological diseases in the face of their increasing prevalence is a question that researchers need to think about today. Here, at CD BioSciences, we offer you a high-resolution 3D bioprinting 3Dmicroflu™ technology platform for the construction of in vitro models for the study of neurological diseases mechanisms. Our experienced team of experts can design and customise models for different neurological diseases, utilising 3Dmicroflu™ technology platform for high precision and high resolution printing that realistically reflects the physiological environment in vivo, thus advancing your research into the relevant disease mechanisms.
Fig. 1. 3Dmicroflu™ for the construction of neurological structures in vitro
The flexibility of 3Dmicroflu™ technology platform allows customisation for different neurological diseases, providing more options and convenience for your experimental projects.
The brain is the most complex tissue in the body and can be difficult to construct in vitro. However, our high-precision and high-resolution 3Dmicroflu™ 3D printing technology platform enables the construction of models of the nervous system that truly reflect the in vivo physiological environment.
Personalised drug development is made possible through our 3D printing 3Dmicroflu™ technology platform using patients' cells to build personalised disease models.
If you are interested in our high-resolution 3Dmicroflu™ 3D bioprinting technology platform, please contact us now for professional services. All services are available on a 24/7/365 basis.